Genmab — Januar 2018
-
Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors
Worry about Amazon? That's exactly what J&J's CEO said at the J.P. Morgan Healthcare Conference that he wants his company to do.
Yahoo Finance (finance.yahoo.com)
-
Hvorfor er det spændende? Du må savne spænding JKY:-) Han siger jo det samme de har sagt de sidste 4-5 år, at de vil købe når de føler for det, gab! not-too-distant future oversætter jeg til 0.5 - 3 år grundet tidligere udtalelser. Sry for at ødelægge stemningen.
-
Netop Bulder
-
-
-
-
-
Th1/17 hybrid T cells offer potent and durable anti-tumor response in preclinical model
Adoptive cell therapy for cancer involves harvesting T cells from a patient and expanding and sometimes modifying them in the laboratory before reinfusion. It has been challenging to create T cells that are both potent and durable. In a new study, researchers report the potent anti-tumor properties of hybrid Th1/Th17 cells that combine the cancer-fighting properties of Th1 cells and the ability of Th17 cells to self-renew and regenerate.
ScienceDaily (www.sciencedaily.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind